Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis

Overview of attention for article published in Frontiers in immunology, December 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Readers on

mendeley: 23 Mendeley

Summary News X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,692 followers.

Identification and Clinical Validation of Extracellular Proteins as Biomarkers in Relapsing-Remitting Multiple Sclerosis https://t.co/6YyTpNT5vr

13 Feb 2022

Reply Repost Favourite

Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis https://t.co/wFpaeK53yi

24 Dec 2021

Reply Repost Favourite

New Research: Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis: Background Multiple sclerosis (MS) is a demyelinating disease of the central nervous… https://t.co/JTt

07 Dec 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.